Staff Directory Contact Us

The Nathan S. Kline Institute for Psychiatric Research

Analytical Psychopharmacology

Laboratories

Yaragudri Lab

Lab Name
#878cb4
Scientific Consultant
Research Intern

Our research is focused on understanding the role of brain signaling pathways in neurobiology of depressive and alcohol abuse disorders, and their comorbidity with anxiety behavior. 

Overview

Major depressive disorder (MDD) is a challenging psychiatric problem with variation in symptoms and response to treatment. It remains a common and under-treated illness, resulting in a high degree of disability and mortality worldwide. It is also intriguing to note the higher prevalence of MDD in women than men. To this end, we are examining if there are any gender-specific differences in signaling pathways mainly endocannabinoid system associated with depressive behavior. The other area of our research actively being perused is to understand the neurochemical mechanisms of alcohol abuse disorder (reward, tolerance, dependence and relapse). Our laboratory is also interested in examining the neurochemical and behavioral effects of gestational cannabis and alcohol exposure on offspring. To achieve these goals, we utilize rodent models (mouse and rat) and human postmortem brains, and employ various biochemical, genetic, behavioral, and pharmacological approaches. Our long-term aim is to develop effective therapeutic interventions through understanding of molecular mechanisms underlying these disorders.

Current Investigations
  • Delineation of the molecular mechanism/s of depressive behavior and increased alcohol consumption. 
  • Study of gender-specific differences in brain targets in depressive behavior.
  • Evaluation of pharmacological agents for the treatment of depressive and alcohol abuse disorders.